Tuberostemonine reverses multidrug resistance in chronic myelogenous leukemia cells K562/ADR

Objective: To investigate the reversal effect of tuberostemonine on MDR in myelogenous leukemia cells K562/ADR. Methods: Human myelogenous leukemia cells K562 and their adriamycin-resistance cells K562/ADR were used. The growth curve of cells treated by tuberostemonine and the Non-toxic concentratio...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Cancer
Auteurs principaux: Wang, Yu Jia, Zhao, Huan Dong, Zhu, Cai Feng, Li, Jian, Xie, Hong Juan, Chen, Yu Xiang
Format: Artigo
Langue:Inglês
Publié: Ivyspring International Publisher 2017
Sujets:
Research Paper
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5436265/
https://ncbi.nlm.nih.gov/pubmed/28529625
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.17688
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires